Kohler, Heike

Link to this page

Authority KeyName Variants
ff87b903-5efe-4433-b525-906632c96831
  • Kohler, Heike (5)
Projects
No records found.

Author's Bibliography

Cooperation of intrathymic T15 idiotype-bearing B and complementary T cells in ontogeny of natural Treg cells involved in establishment of T15 clonal dominance

Metlaš, Radmila; Srdić-Rajić, Tatjana; Kohler, Heike

(2018)

TY  - JOUR
AU  - Metlaš, Radmila
AU  - Srdić-Rajić, Tatjana
AU  - Kohler, Heike
PY  - 2018
UR  - https://linkinghub.elsevier.com/retrieve/pii/S0165247818301147
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/7793
AB  - The mechanisms for dominant T15 idiotype selection are not well understood, yet the significance of idiotypic regulation has been suggested. We proposed that to become dominant V regions of a given subset of B-1a cell must establish a functional idiotypic network with complementary T cells. Features required for the cells involved in immune network and steps preceding the establishment of clonal dominance are suggested. © 2018
T2  - Immunology Letters
T1  - Cooperation of intrathymic T15 idiotype-bearing B and complementary T cells in ontogeny of natural Treg cells involved in establishment of T15 clonal dominance
VL  - 200
SP  - 52
EP  - 54
DO  - 10.1016/j.imlet.2018.07.002
ER  - 
@article{
author = "Metlaš, Radmila and Srdić-Rajić, Tatjana and Kohler, Heike",
year = "2018",
abstract = "The mechanisms for dominant T15 idiotype selection are not well understood, yet the significance of idiotypic regulation has been suggested. We proposed that to become dominant V regions of a given subset of B-1a cell must establish a functional idiotypic network with complementary T cells. Features required for the cells involved in immune network and steps preceding the establishment of clonal dominance are suggested. © 2018",
journal = "Immunology Letters",
title = "Cooperation of intrathymic T15 idiotype-bearing B and complementary T cells in ontogeny of natural Treg cells involved in establishment of T15 clonal dominance",
volume = "200",
pages = "52-54",
doi = "10.1016/j.imlet.2018.07.002"
}
Metlaš, R., Srdić-Rajić, T.,& Kohler, H.. (2018). Cooperation of intrathymic T15 idiotype-bearing B and complementary T cells in ontogeny of natural Treg cells involved in establishment of T15 clonal dominance. in Immunology Letters, 200, 52-54.
https://doi.org/10.1016/j.imlet.2018.07.002
Metlaš R, Srdić-Rajić T, Kohler H. Cooperation of intrathymic T15 idiotype-bearing B and complementary T cells in ontogeny of natural Treg cells involved in establishment of T15 clonal dominance. in Immunology Letters. 2018;200:52-54.
doi:10.1016/j.imlet.2018.07.002 .
Metlaš, Radmila, Srdić-Rajić, Tatjana, Kohler, Heike, "Cooperation of intrathymic T15 idiotype-bearing B and complementary T cells in ontogeny of natural Treg cells involved in establishment of T15 clonal dominance" in Immunology Letters, 200 (2018):52-54,
https://doi.org/10.1016/j.imlet.2018.07.002 . .
3
2
4

AIDS vaccine: State of the art at the beginning of the third millennium

Veljković, Veljko; Kohler, Heike; Muller, S

(2004)

TY  - JOUR
AU  - Veljković, Veljko
AU  - Kohler, Heike
AU  - Muller, S
PY  - 2004
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/2804
AB  - This overview briefly summarizes the current status of global AIDS epidemic, especially pointing out how this pandemic looked in the last year of the second millennium. We also give a brief overview of the state of the art in development of AIDS vaccines together with a short summary of the supporting data and obstacles in this development.
T2  - International Reviews of Immunology
T1  - AIDS vaccine: State of the art at the beginning of the third millennium
VL  - 23
IS  - 5-6
SP  - 369
EP  - 381
DO  - 10.1080/08830180490432730
ER  - 
@article{
author = "Veljković, Veljko and Kohler, Heike and Muller, S",
year = "2004",
abstract = "This overview briefly summarizes the current status of global AIDS epidemic, especially pointing out how this pandemic looked in the last year of the second millennium. We also give a brief overview of the state of the art in development of AIDS vaccines together with a short summary of the supporting data and obstacles in this development.",
journal = "International Reviews of Immunology",
title = "AIDS vaccine: State of the art at the beginning of the third millennium",
volume = "23",
number = "5-6",
pages = "369-381",
doi = "10.1080/08830180490432730"
}
Veljković, V., Kohler, H.,& Muller, S.. (2004). AIDS vaccine: State of the art at the beginning of the third millennium. in International Reviews of Immunology, 23(5-6), 369-381.
https://doi.org/10.1080/08830180490432730
Veljković V, Kohler H, Muller S. AIDS vaccine: State of the art at the beginning of the third millennium. in International Reviews of Immunology. 2004;23(5-6):369-381.
doi:10.1080/08830180490432730 .
Veljković, Veljko, Kohler, Heike, Muller, S, "AIDS vaccine: State of the art at the beginning of the third millennium" in International Reviews of Immunology, 23, no. 5-6 (2004):369-381,
https://doi.org/10.1080/08830180490432730 . .
1

Does VaxGen hide the breakthrough infections?

Veljković, Veljko; Muller, S; Kohler, Heike

(2003)

TY  - JOUR
AU  - Veljković, Veljko
AU  - Muller, S
AU  - Kohler, Heike
PY  - 2003
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/2632
T2  - Lancet
T1  - Does VaxGen hide the breakthrough infections?
VL  - 361
IS  - 9370
SP  - 1743
EP  - 1744
DO  - 10.1016/S0140-6736(03)13344-2
ER  - 
@article{
author = "Veljković, Veljko and Muller, S and Kohler, Heike",
year = "2003",
journal = "Lancet",
title = "Does VaxGen hide the breakthrough infections?",
volume = "361",
number = "9370",
pages = "1743-1744",
doi = "10.1016/S0140-6736(03)13344-2"
}
Veljković, V., Muller, S.,& Kohler, H.. (2003). Does VaxGen hide the breakthrough infections?. in Lancet, 361(9370), 1743-1744.
https://doi.org/10.1016/S0140-6736(03)13344-2
Veljković V, Muller S, Kohler H. Does VaxGen hide the breakthrough infections?. in Lancet. 2003;361(9370):1743-1744.
doi:10.1016/S0140-6736(03)13344-2 .
Veljković, Veljko, Muller, S, Kohler, Heike, "Does VaxGen hide the breakthrough infections?" in Lancet, 361, no. 9370 (2003):1743-1744,
https://doi.org/10.1016/S0140-6736(03)13344-2 . .
1
3
3
3

AIDSVAX results: an important open question

Veljković, Veljko; Muller, S; Kohler, Heike

(2003)

TY  - JOUR
AU  - Veljković, Veljko
AU  - Muller, S
AU  - Kohler, Heike
PY  - 2003
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/2665
AB  - Research and clinical data reported during last 10 years indicate the possibility that AIDS vaccines based on the HIV-1 envelope protein gp120 may be worse then useless. A correct assessment of the safety of these AIDS vaccines can not be possible without data which will allow comparison of the disease status between breakthrough HIV infected vaccinated volunteers and those from the control group. Results of the recently finished clinical trial of AIDSVAX represent a good base for this important analysis. (C) 2003 Elsevier Science Ltd. All rights reserved.
T2  - Vaccine
T1  - AIDSVAX results: an important open question
VL  - 21
IS  - 25-26
SP  - 3528
EP  - 3529
DO  - 10.1016/S0264-410X(03)00324-4
ER  - 
@article{
author = "Veljković, Veljko and Muller, S and Kohler, Heike",
year = "2003",
abstract = "Research and clinical data reported during last 10 years indicate the possibility that AIDS vaccines based on the HIV-1 envelope protein gp120 may be worse then useless. A correct assessment of the safety of these AIDS vaccines can not be possible without data which will allow comparison of the disease status between breakthrough HIV infected vaccinated volunteers and those from the control group. Results of the recently finished clinical trial of AIDSVAX represent a good base for this important analysis. (C) 2003 Elsevier Science Ltd. All rights reserved.",
journal = "Vaccine",
title = "AIDSVAX results: an important open question",
volume = "21",
number = "25-26",
pages = "3528-3529",
doi = "10.1016/S0264-410X(03)00324-4"
}
Veljković, V., Muller, S.,& Kohler, H.. (2003). AIDSVAX results: an important open question. in Vaccine, 21(25-26), 3528-3529.
https://doi.org/10.1016/S0264-410X(03)00324-4
Veljković V, Muller S, Kohler H. AIDSVAX results: an important open question. in Vaccine. 2003;21(25-26):3528-3529.
doi:10.1016/S0264-410X(03)00324-4 .
Veljković, Veljko, Muller, S, Kohler, Heike, "AIDSVAX results: an important open question" in Vaccine, 21, no. 25-26 (2003):3528-3529,
https://doi.org/10.1016/S0264-410X(03)00324-4 . .
3
3
4

AIDS epidemic at the beginning of the third millennium: time for a new AIDS vaccine strategy

Veljković, Veljko; Metlaš, Radmila; Kohler, Heike; Urnovitz, HB; Prljić, Jelena; Veljković, Nevena V.; Johnson, Emmett; Muller, S

(2001)

TY  - JOUR
AU  - Veljković, Veljko
AU  - Metlaš, Radmila
AU  - Kohler, Heike
AU  - Urnovitz, HB
AU  - Prljić, Jelena
AU  - Veljković, Nevena V.
AU  - Johnson, Emmett
AU  - Muller, S
PY  - 2001
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/2419
AB  - Current expansion of AIDS pandemic significantly accelerates AIDS vaccine research resulting in development and clinical testing of several AIDS vaccine candidates. At the same time, available experimental and clinical data demonstrate that current AIDS vaccine strategy is unsuccessful resulting in development of inefficient and harmful vaccines. This overview briefly summarizes reported results which point out the requirement for moratorium on the current clinical trials of HIV-1 gp120/160 vaccines and urgent need for development of a new, efficient and safe AIDS vaccine strategy. (C) 2001 Elsevier Science Ltd. All rights reserved.
T2  - Vaccine
T1  - AIDS epidemic at the beginning of the third millennium: time for a new AIDS vaccine strategy
VL  - 19
IS  - 15-16
SP  - 1855
EP  - 1862
DO  - 10.1016/S0264-410X(00)00194-8
ER  - 
@article{
author = "Veljković, Veljko and Metlaš, Radmila and Kohler, Heike and Urnovitz, HB and Prljić, Jelena and Veljković, Nevena V. and Johnson, Emmett and Muller, S",
year = "2001",
abstract = "Current expansion of AIDS pandemic significantly accelerates AIDS vaccine research resulting in development and clinical testing of several AIDS vaccine candidates. At the same time, available experimental and clinical data demonstrate that current AIDS vaccine strategy is unsuccessful resulting in development of inefficient and harmful vaccines. This overview briefly summarizes reported results which point out the requirement for moratorium on the current clinical trials of HIV-1 gp120/160 vaccines and urgent need for development of a new, efficient and safe AIDS vaccine strategy. (C) 2001 Elsevier Science Ltd. All rights reserved.",
journal = "Vaccine",
title = "AIDS epidemic at the beginning of the third millennium: time for a new AIDS vaccine strategy",
volume = "19",
number = "15-16",
pages = "1855-1862",
doi = "10.1016/S0264-410X(00)00194-8"
}
Veljković, V., Metlaš, R., Kohler, H., Urnovitz, H., Prljić, J., Veljković, N. V., Johnson, E.,& Muller, S.. (2001). AIDS epidemic at the beginning of the third millennium: time for a new AIDS vaccine strategy. in Vaccine, 19(15-16), 1855-1862.
https://doi.org/10.1016/S0264-410X(00)00194-8
Veljković V, Metlaš R, Kohler H, Urnovitz H, Prljić J, Veljković NV, Johnson E, Muller S. AIDS epidemic at the beginning of the third millennium: time for a new AIDS vaccine strategy. in Vaccine. 2001;19(15-16):1855-1862.
doi:10.1016/S0264-410X(00)00194-8 .
Veljković, Veljko, Metlaš, Radmila, Kohler, Heike, Urnovitz, HB, Prljić, Jelena, Veljković, Nevena V., Johnson, Emmett, Muller, S, "AIDS epidemic at the beginning of the third millennium: time for a new AIDS vaccine strategy" in Vaccine, 19, no. 15-16 (2001):1855-1862,
https://doi.org/10.1016/S0264-410X(00)00194-8 . .
4
14
15
17